American Association for the Study of Liver Diseases and the International Liver Transplantation Society Course (AASLD/ILTS), Part 4: Contemporary Challenges (Ticketed)

Nov 08 2025

Convention Center: Room 202, Level 2

2:00 PM - 3:30 PM

Ticketed Event

World Class Speakers

Kymberly D Watt, MD

Kymberly D Watt, MD

Sezai Yilmaz, MD

Sezai Yilmaz, MD

Emily R Perito, MD, MAS

Emily R Perito, MD, MAS

University of California San Francisco

Valeria M Mas, PhD

Valeria M Mas, PhD

University of Maryland

Prasun K Jalal, MD, FRCP (UK), FAASLD, FASGE, AGAF, FACG

Prasun K Jalal, MD, FRCP (UK), FAASLD, FASGE, AGAF, FACG

Baylor College of Medicine

Ryutaro P Hirose, MD

Ryutaro P Hirose, MD

University of Washington Medical Center

Description

Experts address current and emerging challenges in liver transplantation, including recurrence of metabolic syndrome post transplant, pediatric transplantation complexities, and the utility of posttransplant biomarkers. The potential of paired exchange to broaden donor options is also examined.

Journey Maps

Transplant

Presentations

2:00 PM - 2:15 PM

Oct 09 2026

Convention Center - Room 202, Level 2

Treatment of Recurrent Metabolic Syndrome in Liver Transplant

Kymberly D Watt, MD , Presenter

Transplant

2:15 PM - 2:30 PM

Oct 09 2026

Convention Center - Room 202, Level 2

Paired Exchange in Liver Transplant: Are We Ready for Prime Time?

Sezai Yilmaz, MD , Presenter

Transplant

2:30 PM - 2:45 PM

Oct 09 2026

Convention Center - Room 202, Level 2

Immunosuppression in Pediatric Liver Transplantation: Playing the Long Game

Emily R Perito, MD, MAS , Presenter

Transplant

2:45 PM - 3:00 PM

Oct 09 2026

Convention Center - Room 202, Level 2

The Role of Biomarkers in Managing Post Liver Transplant Patients

Valeria M Mas, PhD , Presenter

Transplant

3:00 PM - 3:30 PM

Oct 09 2026

Convention Center - Room 202, Level 2

Q&A and Panel Discussion

Prasun K Jalal, MD, FRCP (UK), FAASLD, FASGE, AGAF, FACG , Moderator

Transplant

Objectives

Outline contemporary challenges in liver transplantation including new and emerging treatment for recurrence of metabolic syndrome, management of pediatric patients, and the role of biomarkers.
Discuss new treatment for the recurrence of metabolic syndrome post liver transplantation.
Review the role of biomarkers post liver transplantation.
Explain the potential future expansion of donor pools via paired exchange.

Chair

Ryutaro P Hirose, MD

University of Washington Medical Center

Chair

Ramesh Batra, MD, MA(Bioethics), FRCS

University of Arizona

Chair

Nazia Selzner, MD, PhD

University of Toronto